FFCP PHASE1:Mm9::chr5:136532993..136533001,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=69665|HGNC=|MCL_coexpression_id=106|UniProt=D3YZ16|association_with_transcript=-59bp_to_ENSMUST00000111137_5end|description=CAGE_peak_11_at_2310043J07Rik_5end|id=chr5:136532993..136533001,+|ontology_enrichment_celltype=CL:0000068!2.97e-10!3;CL:0002202!2.97e-10!3;CL:0000069!2.97e-10!3;CL:0002632!2.97e-10!3;CL:0002368!2.97e-10!3;CL:0000307!2.97e-10!3;CL:0000377!2.97e-10!3|ontology_enrichment_celltype_v019_2=|ontology_enrichment_disease=|ontology_enrichment_disease_v019_2=|ontology_enrichment_uberon=UBERON:0003126!2.97e-10!3;UBERON:0001005!2.97e-10!3;UBERON:0007196!2.97e-10!3;UBERON:0001558!2.97e-10!3;UBERON:0006834!1.56e-08!1;UBERON:0003134!1.69e-08!8;UBERON:0000305!2.98e-08!1;UBERON:0005795!4.12e-08!4;UBERON:0000995!4.12e-08!4;UBERON:0000474!1.31e-07!9|ontology_enrichment_uberon_v019_2=UBERON:0006834,2.74e-44,1;UBERON:0005795,4.54e-44,4;UBERON:0000995,4.54e-44,4;UBERON:0003975,1.42e-35,5;UBERON:0003134,8.41e-23,8;UBERON:0004175,1.98e-20,9;UBERON:0000474,1.98e-20,9;UBERON:0003100,5.67e-17,11;UBERON:0003133,1.75e-08,24;UBERON:0005156,6.33e-08,26;UBERON:0000990,6.33e-08,26|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.216491041011214,0.760079596425296,0,0.11418387971906,0,0,0,0,0,0,0,0,0.247194967734374,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.195133647857799,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.162886959353576,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.129358683782755,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.134864346384821,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5.44279178808428,1.09890974560359,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0574354689556133,0,0,0,0,0,0.342869252385415,0,0,0.145346416632329,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0|short_description=p11@2310043J07Rik}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=entrezgene:69665 | |||
|HGNC= | |||
|MCL_coexpression_id=106 | |||
|TSSclassifier=NA | |||
|UniProt=uniprot:D3YZ16 | |||
|association_with_transcript=-59bp_to_ENSMUST00000111137_5end | |||
|cluster_id=chr5:136532993..136533001,+ | |||
|description=CAGE_peak_11_at_2310043J07Rik_5end | |||
|id=chr5:136532993..136533001,+ | |||
|ontology_enrichment_celltype=CL:0000068!2.97e-10!3;CL:0002202!2.97e-10!3;CL:0000069!2.97e-10!3;CL:0002632!2.97e-10!3;CL:0002368!2.97e-10!3;CL:0000307!2.97e-10!3;CL:0000377!2.97e-10!3 | |||
|ontology_enrichment_celltype_v019_2= | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon=UBERON:0003126!2.97e-10!3;UBERON:0001005!2.97e-10!3;UBERON:0007196!2.97e-10!3;UBERON:0001558!2.97e-10!3;UBERON:0006834!1.56e-08!1;UBERON:0003134!1.69e-08!8;UBERON:0000305!2.98e-08!1;UBERON:0005795!4.12e-08!4;UBERON:0000995!4.12e-08!4;UBERON:0000474!1.31e-07!9 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0006834,2.74e-44,1;UBERON:0005795,4.54e-44,4;UBERON:0000995,4.54e-44,4;UBERON:0003975,1.42e-35,5;UBERON:0003134,8.41e-23,8;UBERON:0004175,1.98e-20,9;UBERON:0000474,1.98e-20,9;UBERON:0003100,5.67e-17,11;UBERON:0003133,1.75e-08,24;UBERON:0005156,6.33e-08,26;UBERON:0000990,6.33e-08,26 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.216491041011214,0.760079596425296,0,0.11418387971906,0,0,0,0,0,0,0,0,0.247194967734374,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.195133647857799,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.162886959353576,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.129358683782755,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.134864346384821,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5.44279178808428,1.09890974560359,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0574354689556133,0,0,0,0,0,0.342869252385415,0,0,0.145346416632329,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p11@2310043J07Rik | |||
}} |
Revision as of 19:57, 3 August 2015
Short description: | p11@2310043J07Rik |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_11_at_2310043J07Rik_5end |
Coexpression cluster: | MCL_coexpression_mm9:106 |
Association with transcript: | -59bp_to_ENSMUST00000111137_5end |
EntrezGene: | 69665 |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
uterus or analog | 2.74e-44 | 1 |
embryonic uterus | 4.54e-44 | 4 |
uterus | 4.54e-44 | 4 |
internal female genitalia | 1.42e-35 | 5 |
female reproductive organ | 8.41e-23 | 8 |
internal genitalia | 1.98e-20 | 9 |
female reproductive system | 1.98e-20 | 9 |
female organism | 5.67e-17 | 11 |
reproductive organ | 1.75e-08 | 24 |
reproductive structure | 6.33e-08 | 26 |
reproductive system | 6.33e-08 | 26 |